ATOM.NASDAQAtomera INC

8-K: Atomera Reports Q4 and Fiscal Year 2024 Results, Highlights Progress with ST Microelectronics

Sentiment:

Earnings Release


Atomera Incorporated announced its Q4 and fiscal year 2024 financial results, reporting a net loss and highlighting continued progress toward commercialization with ST Microelectronics.

Worse than expectedRevenue decreased from $550,000 in fiscal year 2023 to $135,000 in fiscal year 2024.

Summary

  • Atomera Incorporated announced its financial results for the fourth quarter and fiscal year ended December 31, 2024.
  • The company incurred a net loss of $4.7 million, or $0.16 per share, in Q4 2024, compared to a net loss of $4.6 million, or $0.18 per share, in Q4 2023.
  • Adjusted EBITDA for Q4 2024 was a loss of $3.9 million, versus a $3.7 million loss in Q4 2023.
  • For fiscal year 2024, revenue was $135,000, a decrease from $550,000 in fiscal year 2023.
  • The net loss for fiscal year 2024 was $18.4 million, or $0.68 per share, compared to a net loss of $19.8 million, or $0.80 per share, in fiscal year 2023.
  • Adjusted EBITDA for fiscal year 2024 was a loss of $15.4 million, compared to a loss of $16.6 million in fiscal year 2023.
  • The company's cash, cash equivalents, and short-term investments totaled $26.8 million as of December 31, 2024, up from $19.5 million at the end of 2023.
  • The total number of shares outstanding was 30.1 million as of December 31, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company highlights progress with key customers and an increase in cash reserves, the decrease in revenue and continued net losses temper the overall outlook.

Positives

  • Atomera is making continued progress toward commercialization at ST Microelectronics.
  • The company has expanded its offerings for gate-all-around products, which are foundational for advanced AI devices.
  • Atomera has initiated development efforts with two large customers.
  • Cash, cash equivalents, and short-term investments increased to $26.8 million as of December 31, 2024, compared to $19.5 million at the end of 2023.
  • The net loss decreased from $19.8 million in fiscal year 2023 to $18.4 million in fiscal year 2024.
  • Adjusted EBITDA loss decreased from $16.6 million in fiscal year 2023 to $15.4 million in fiscal year 2024.
  • Atomera has a strong and growing IP portfolio with 347 patents granted and pending.

Negatives

  • Revenue decreased from $550,000 in fiscal year 2023 to $135,000 in fiscal year 2024.
  • The company incurred a net loss of $4.7 million in Q4 2024.
  • The net loss for fiscal year 2024 was $18.4 million.

Risks

  • The company has only recognized minimal engineering services and licensing revenues to date.
  • Licensees or JDA customers may not advance to royalty-based manufacturing and distribution licenses.
  • The company's ability to raise sufficient capital is a risk.
  • Protecting proprietary technology, trade secrets, and know-how is a risk.

Future Outlook

The company is focused on deploying its MST technology into the semiconductor industry and believes the semiconductor industry is currently in an ideal state to adopt new technology.

Management Comments

  • Recent progress with large customers has reinforced the attractiveness of MST to solve some of the most difficult problems faced by semiconductor companies, which is the key to Atomera licensing customers and bringing our technology to production, said Scott Bibaud, President and CEO.
  • The semiconductor industry is currently in an ideal state to adopt new technology and the performance improvements enabled by MST are compelling to fabs and foundries seeking to gain cost-effective advantages in highly competitive markets.

Industry Context

Atomera is positioning its MST technology as a solution to improve performance and power efficiency in semiconductor transistors, particularly in advanced nodes and gate-all-around architectures, which are critical for the development of AI devices.

Comparison to Industry Standards

  • Atomera's MST technology is being targeted at major semiconductor manufacturers, including ST Microelectronics, and aims to improve transistor performance, which is a key focus for companies like TSMC, Samsung, and Intel as they compete in advanced node manufacturing.
  • The company's focus on gate-all-around (GAA) transistors aligns with the industry's shift towards more advanced transistor architectures to improve performance and power efficiency, similar to efforts by companies like IBM and GlobalFoundries.
  • The company's IP portfolio of 347 patents granted and pending is a significant asset in the competitive semiconductor technology licensing market, where companies like ARM and Qualcomm hold extensive patent portfolios.

Stakeholder Impact

  • Shareholders will be interested in the company's progress towards commercialization and its ability to generate revenue.
  • Employees are likely focused on the company's continued development efforts and partnerships with large customers.
  • Customers are interested in the potential performance improvements offered by Atomera's MST technology.

Next Steps

  • Atomera will host a live video webinar on February 11, 2025, to discuss its financial results and recent progress.

Key Dates

DateDescription
February 15, 2024Date of Annual Report on Form 10-K filed with the SEC
December 31, 2024End of the fourth quarter and fiscal year 2024
February 11, 2025Date of press release and investor presentation announcing Q4 and fiscal year 2024 results; Date of earnings call webinar

Keywords

Atomera, MST, semiconductor, licensing, financial results, net loss, EBITDA, revenue, patents, ST Microelectronics, gate-all-around, AI devices

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.